13:56 IST
BSE
Results Update
Fredun Pharmaceuticals Results Update
Fredun Pharmaceuticals reported Q1 FY27 total income of ₹228.25 Crore, a 90% YoY increase. Net profit rose 94.6% to ₹13.17 Crore during the same period.
Fredun Pharmaceuticals Ltd
- Share price
- ₹1,475.00
- Market cap
- ₹2,107 Cr
- Revenue (annual)
- ₹635.5 Cr
- Net profit (annual)
- ₹32.62 Cr
- P/E (TTM)
- 48.1×Sector 47.4×
- Promoter holding
- 44.57%+0.40% QoQ
- FII holding
- 1.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 5Financial Results 4Earnings Call 3Results Update 2Other Announcement 2Bonus Issue 2Annual General Meeting 2Acquisition 2Product Launch 1Dividend 1Debt & Borrowing 1Capacity Expansion 1Business Update 1Board Meeting Outcome 1Board Meeting Date 1Annual Report 1
Time
2 announcements with these filters
17:50 IST
BSE
Results Update
Fredun Pharmaceuticals Results Update
Fredun Pharmaceuticals reported FY26 revenue of ₹639.12 Crore, marking a 40% YoY jump. EBITDA surged 72% while PAT rose ~60% to ₹33.21 Crore.
- Value
- ₹639.1 Cr